Iodine-124 Evuzumitide
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 150 patients (estimated)
- Sponsors
- Oregon Health and Science University
- Collaborators
- Attralus, Inc.
- Tags
- Amyloid
- Trial Type
- Supportive
- Last Update
- 4 months ago
- SparkCures ID
- 2064
- NCT Identifier
- NCT05758493
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.